Nexstim secures Business Finland funding for the development of wireless EMG devices

Helsinki, Finland: 25 October 2018 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing, and marketing pioneering navigated personalised, non-invasive brain stimulation systems for the treatment of Major Depression Disorder (MDD), announces today that it has secured € 342 thousand in the form of future R&D loans from Business Finland. The funding is part of the ELASTRONICS project to develop wireless Electromyography (EMG) devices. ELASTRONICS (Enabling the Future of Wearable Electronics) is Finland's largest research project for stretchable electronics technologies and production processes.

More info on Nexstim's website


Next > Capricorn’s Sustainable Chemistry Fund joins Black Bear funding round to solve the global waste tire problem and slash CO2

Previous > Sequana Medical establishes new corporate headquarters in Ghent, Belgium and raises € 8.5 million from leading Belgian investors including Newton Biocapital, PMV and SFPI-FPIM as well as existing shareholders